ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Since publication of the 2018 guidelines, the area of glucose monitoring has evolved, especially as regards continuous glucose monitoring (CGM) systems.CGM is more widely available in many parts of the world; latest generation devices are factory-calibrated, more accurate, and do not need a confirmatory fingerstick blood glucose measurement.More studies regarding the efficacy of CGM systems, irrespective of the type of insulin delivery, are available including long-term observational studies.With increased availability and wider use, practical considerations related to daily CGM use (e.g., skin issues, physical activity) as well as educational and psychosocial aspects have come to the fore, which are also addressed in this chapter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationNathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Covid-19 and Health Care’s Digital Revolution
Keesara, S., Jonas, A., & Schulman, K. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2005835 · Cited by 1,126 · cited 1×
“133 Pediatric diabetes centers were among those who rapidly expanded telemedicine services to facilitate person care.”
Young-Hyman, D., de Groot, M., Hill-Briggs, F., Gonzalez, J. S., Hood, K., & Peyrot, M. (2016) · Diabetes Care · doi:10.2337/dc16-2053 · Cited by 1,072 · cited 3×
“144 • If psychosocial needs are reported or identified, refer to psychological care provider.”
InfluentialSelf-citationEffectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., Kollman, C., Li, Z., Brown, A. S., & Close, K. L. (2019) · Diabetes Care · doi:10.2337/dc18-1444 · Cited by 793
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 1×
“Current interstitial glucose levels and glucose trend arrows as well as a graph of current and stored glucose readings are provided on demand.(23) As with rtCGM, glucose data from isCGM can be transferred from a smartphone to a webserver for remote glucose monitoring purposes by caregivers or health care professionals.”
Parkes, J. L., Slatin, S. L., Pardo, S., & Ginsberg, B. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1143 · Cited by 620
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-7-199804010-00001 · Cited by 546
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Miller, K. M., Beck, R. W., Bergenstal, R. M., Goland, R. S., Haller, M. J., McGill, J. B., Rodriguez, H., Simmons, J. H., Hirsch, I. B., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1770 · Cited by 505
Maiorino, M. I., Signoriello, S., Maio, A., Chiodini, P., Bellastella, G., Scappaticcio, L., Longo, M., Giugliano, D., & Esposito, K. (2020) · Diabetes Care · doi:10.2337/dc19-1459 · Cited by 364
Diabetes distress among adolescents with type 1 diabetes: a systematic review
Hagger, V., Hendrieckx, C., Sturt, J., Skinner, T. C., & Speight, J. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0694-2 · Cited by 338
Self-citationZiegler, R., Heidtmann, B., Hilgard, D., Hofer, S., Rosenbauer, J., Holl, R., & DPV-Wiss-Initiative, F. T. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00650.x · Cited by 334 · cited 1×
“15 This includes review by the person with diabetes and their caregivers/family in addition to consultation with the diabetes care team.”
Aleppo, G., Ruedy, K. J., Riddlesworth, T. D., Kruger, D. F., Peters, A. L., Hirsch, I., Bergenstal, R. M., Toschi, E., Ahmann, A. J., Shah, V. N., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2482 · Cited by 329
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318
Tanenbaum, M. L., Hanes, S. J., Miller, K. M., Naranjo, D., Bensen, R., & Hood, K. K. (2017) · Diabetes Care · doi:10.2337/dc16-1536 · Cited by 296 · cited 2×
“ety of reasons including cost, too many alarms, concerns about accuracy, and discomfort wearing a device on one's body.(154) Thus, setting”
Self-citationAddala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., Walker, A., Rosenbauer, J., Maahs, D. M., & Holl, R. W. (2021) · Diabetes Care · doi:10.2337/dc20-0257 · Cited by 283 · cited 1×
“5%).(20) Adequate clinic-specific resources and interventions to identify and overcome barriers to”
Charleer, S., De Block, C., Van Huffel, L., Broos, B., Fieuws, S., Nobels, F., Mathieu, C., & Gillard, P. (2020) · Diabetes Care · doi:10.2337/dc19-1610 · Cited by 261
Šoupal, J., Petruželková, L., Grunberger, G., Hásková, A., Flekač, M., Matoulek, M., Mikeš, O., Pelcl, T., Škrha, J., Horová, E., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0888 · Cited by 242
Dunn, T. C., Xu, Y., Hayter, G., & Ajjan, R. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.015 · Cited by 239
DeSalvo, D. J., Miller, K. M., Hermann, J. M., Maahs, D. M., Hofer, S. E., Clements, M. A., Lilienthal, E., Sherr, J. L., Tauschmann, M., Holl, R. W., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12711 · Cited by 233
Self-citationDelays in Minimally Invasive Continuous Glucose Monitoring Devices: A Review of Current Technology
Keenan, D. B., Mastrototaro, J. J., Voskanyan, G., & Steil, G. M. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300528 · Cited by 198 · cited 1×
“digital filters for smoothening of the sensor signal during conversion of the measured sensor signal into a glucose value.(26,27) Sensor performance also may be affected by biomechanical factors such as motion and pressure (typically micro-motion and micro-pressure).”
van den Boom, L., Karges, B., Auzanneau, M., Rami-Merhar, B., Lilienthal, E., von Sengbusch, S., Datz, N., Schröder, C., Kapellen, T., Laimer, M., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0345 · Cited by 191 · cited 1×
“47 63 This positive effect on HbA1c has also been seen in a Swedish registry-based study that described a progressive decrease of HbA1c in very young children during the 2008 – 2018 period, in parallel with the increasing use of pumps and CGM. 64 67 In contrast, registry-based studies have not…”
Adolfsson, P., Riddell, M. C., Taplin, C. E., Davis, E. A., Fournier, P. A., Annan, F., Scaramuzza, A. E., Hasnani, D., & Hofer, S. E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12755 · Cited by 191 · cited 2×
“94,115,116 118 A recent position statement recommends different glycemic ranges before, during and after exercise according to the age group, the type of exercise, the risk for hypoglycemia and in accordance with the trend arrows.”
Deshmukh, H., Wilmot, E. G., Gregory, R., Barnes, D., Narendran, P., Saunders, S., Furlong, N., Kamaruddin, S., Banatwalla, R., Herring, R., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0738 · Cited by 175
Lawton, J., Blackburn, M., Allen, J., Campbell, F., Elleri, D., Leelarathna, L., Rankin, D., Tauschmann, M., Thabit, H., & Hovorka, R. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0239-1 · Cited by 174 · cited 1×
“103,105 Further, ongoing education and support are recognized as essential to overcome barriers to consistent CGM use and as technologies are continuously updated.”
Self-citationHeinemann, L., Schoemaker, M., Schmelzeisen-Redecker, G., Hinzmann, R., Kassab, A., Freckmann, G., Reiterer, F., & Del Re, L. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819855670 · Cited by 170 · cited 1×
“sole performance parameter for CGM systems must be viewed critically.(29) The lower the MARD, the closer CGM readings are to the reference glucose values.”
Alva, S., Bailey, T., Brazg, R., Budiman, E. S., Castorino, K., Christiansen, M. P., Forlenza, G., Kipnes, M., Liljenquist, D. R., & Liu, H. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820958754 · Cited by 164
Self-citationHásková, A., Radovnická, L., Petruželková, L., Parkin, C. G., Grunberger, G., Horová, E., Navrátilová, V., Kádě, O., Matoulek, M., Prázný, M., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0112 · Cited by 146 · cited 3×
“94 The use of predictive hypoglycemia thresholds and rate-of-change in glucose alerts in rtCGM devices, allows prompt action to avoid glycemic fluctuations during and after exercise.”
Van Name, M. A., Hilliard, M. E., Boyle, C. T., Miller, K. M., DeSalvo, D. J., Anderson, B. J., Laffel, L. M., Woerner, S. E., DiMeglio, L. A., & Tamborlane, W. V. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12525 · Cited by 139
Self-citationCardona-Hernandez, R., Schwandt, A., Alkandari, H., Bratke, H., Chobot, A., Coles, N., Corathers, S., Goksen, D., Goss, P., Imane, Z., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1674 · Cited by 129
Self-citationDicembrini, I., Cosentino, C., Monami, M., Mannucci, E., & Pala, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01589-3 · Cited by 106
Helton, K. L., Ratner, B. D., & Wisniewski, N. A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500318 · Cited by 102
Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group, Laffel, L., Harrington, K., Hanono, A., Naik, N., Ambler-Osborn, L., Schultz, A., DiMeglio, L., Woerne, S., Jolivette, H., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1060 · Cited by 95 · cited 1×
“76 Using data from the Slovenian National Registry, Dovc et al demonstrated that the use of CGM was well tolerated by pre-school children and that a positive effect was observed in glucose variability.”
Self-citationJohnson, S. R., Holmes-Walker, D. J., Chee, M., Earnest, A., & Jones, T. W. (2022) · Diabetes Care · doi:10.2337/dc21-1666 · Cited by 86
Addala, A., Maahs, D. M., Scheinker, D., Chertow, S., Leverenz, B., & Prahalad, P. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13082 · Cited by 83
Stress and coping predicts adjustment and glycemic control in adolescents with type 1 diabetes
Jaser, S. S., Patel, N., Xu, M., Tamborlane, W. V., & Grey, M. (2017) · Annals of Behavioral Medicine · doi:10.1007/s12160-016-9825-5 · Cited by 80
Continuous Glucose Monitor Interference With Commonly Prescribed Medications: A Pilot Study
Basu, A., Slama, M. Q., Nicholson, W. T., Langman, L., Peyser, T., Carter, R., & Basu, R. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817697329 · Cited by 77 · cited 1×
“CGM readings may also be affected by ingestion of lisinopril, albuterol, atenolol, and red wine.(38)”
Continuous glucose monitoring in patients with type 1 diabetes using insulin injections
Foster, N. C., Miller, K. M., Tamborlane, W. V., Bergenstal, R. M., & Beck, R. W. (2016) · Diabetes Care · doi:10.2337/dc16-0207 · Cited by 76
Champakanath, A., Akturk, H. K., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N. (2022) · Diabetes Care · doi:10.2337/dc21-2004 · Cited by 76 · cited 1×
“initiated in the first year after T1D diagnosis compared to no CGM use or when CGM initiation after the first year.(96)”
Mulinacci, G., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0257 · Cited by 66
Boucher, S. E., Gray, A. R., Wiltshire, E. J., de Bock, M. I., Galland, B. C., Tomlinson, P. A., Rayns, J. A., MacKenzie, K. E., Chan, H., Rose, S., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0613 · Cited by 51
Self-citationLandau, Z., Abiri, S., Gruber, N., Levy-Shraga, Y., Brener, A., Lebenthal, Y., Barash, G., Pinhas-Hamiel, O., & Rachmiel, M. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1218-8 · Cited by 48 · cited 1×
“80,81,85,87,88 These studies were all performed using first-generation systems without alarms for impending hypo-and hyperglycemia.”
A review of blood glucose monitor accuracy
King, F., Ahn, D., Hsiao, V., Porco, T., & Klonoff, D. C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0232 · Cited by 37 · cited 2×
“ditions might vary significantly from actual SMBG meter performance in real-world settings.(4) Detailed information on the actual performance of SMBG devices is provided by The Diabetes Technology Society Blood Glucose Monitoring System Surveillance Program”
Herman, A., de Montjoye, L., & Baeck, M. (2020) · Contact Dermatitis · doi:10.1111/cod.13529 · Cited by 36 · cited 1×
“124,125 Increasing evidence identifies sensitizing components of sensors and adhesives as factors possibly responsible for skin reactions, including allergic contact dermatitis.”
Inaccurate glucose sensor values after hydroxyurea administration
Tellez, S. E., Hornung, L. N., Courter, J. D., Abu-El-Haija, M., Nathan, J. D., Lawson, S. A., & Elder, D. A. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0490 · Cited by 33 · cited 1×
“In particular, therapeutic doses of hydroxyurea can markedly elevate sensor glucose readings compared with glucose meter values 34 ; likewise, acetaminophen at a dose of 1000 mg can falsely elevate sensor glucose values in certain CGM systems.”
Use of Diabetes Technology in Children
Desrochers, H. R., Schultz, A. T., & Laffel, L. M. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.11.001 · Cited by 29
Self-citationUrakami, T., Yoshida, K., Kuwabara, R., Mine, Y., Aoki, M., Suzuki, J., & Morioka, I. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13618 · Cited by 26
Cited by
Zhou, Y., Sardana, D., Kuroko, S., Haszard, J. J., de Block, M. I., Weng, J., Jefferies, C., & Wheeler, B. J. (2024) · Diabetic Medicine · doi:10.1111/dme.15280 · Cited by 25
Self-citationChow, E., Virani, A., Pinkney, S., Abdulhussein, F. S., van Rooij, T., Görges, M., Wasserman, W., Bone, J., Longstaff, H., & Amed, S. (2024) · Journal of Medical Internet Research · doi:10.2196/53657 · Cited by 12
Albanese-O’Neill, A. (2023) · Diabetes Spectrum · doi:10.2337/dsi23-0006 · Cited by 9
Metadata
- Authors
- Tauschmann, M., Forlenza, G., Hood, K., Cardona‐Hernandez, R., Giani, E., Hendrieckx, C., DeSalvo, D. J., Laffel, L. M., Saboo, B., Wheeler, B. J., Latpev, D. N., Yarhere, I., & DiMeglio, L. A.
- Venue
- Pediatric Diabetes
- Publisher
- Hindawi Limited
- Published
- 2022-12
- Volume
- 23
- Issue
- 8
- Pages
- 1390-1405
- ISSN
- 1399-543X (ISSN-L)
- 1399-5448
- OpenAlex
- W4311973329
- Cited by
- 100
- References
- 53
- FWCI
- 11.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.